| Literature DB >> 35233356 |
Chun-Hou Huang1, Shen-Feng Chao2,3, Yi-Tso Cheng3,4, Pei-Chun Lai5, I-Hsin Lin6, Tai-Chu Peng1.
Abstract
This study aimed to assess evidence for the effect of movement-based mind-body interventions (MMBIs) for cardiac rehabilitation (CR). Six databases were searched from January 1995 to September 2020. All randomized controlled trials (RCTs) evaluated the effect of MMBIs on heart disease (HD) patients' physical and psychological outcomes. Two reviewers independently assessed the quality of all the included studies using the revised Cochrane risk-of-bias tool for RCTs. Sixteen RCTs (5160 participants) published between 1996 and 2020 met all inclusion criteria. In total, these studies investigated the effect of MMBIs for CR. Outcome measures that emerged in these studies included physical and psychological, and/or biochemical parameters to comprehensively evaluate the effects of MMBIs on HD patients. Overall, these studies suggest that MMBIs seem to be an alternative with the optimal CR option. Copyright:Entities:
Keywords: Cardiac rehabilitation; Heart disease; Movement-based mind-body interventions
Year: 2021 PMID: 35233356 PMCID: PMC8830548 DOI: 10.4103/tcmj.tcmj_277_20
Source DB: PubMed Journal: Tzu Chi Med J ISSN: 1016-3190
Figure 1PRISMA flow diagram showing the number of studies identified and selected for inclusion in the literature review
Summary of included studies of movement-based mind-body interventions for cardiac rehabilitation
| Study | Country | Population | Intervention group | Control group | Outcomes | Results | Dropout rates | Adverse events |
|---|---|---|---|---|---|---|---|---|
| Barrow | England | SBP | SBP, DBP: No significant differences were found between the groups | IG: 21.8% | No adverse events | |||
| Caminiti | Italy | 6MWT | 6MWT: Significant increase in the IG | Not reported | No adverse events | |||
| Channer | United Kingdom | Study 1 | SBP | HR: Significant decrease in resting HR in the IG | Not reported | Not reported | ||
| Chen | Taiwan | PFS | PFS: Significant decrease in the IG | IG: 23% | No adverse events | |||
| Chen | China | NT pro-BNP | NT pro-BNP: Significant decrease in the IG | Dropouts: IG: 10.4% | No adverse events | |||
| Eraballi | India | WHOQOL- | WHOQOL-BREF: Significant improvement in IG after 1 year and nonsignificant change in CG | IG: 32% | Not reported | |||
| Lin | China | QOL | QOL and SAQ: Significant increase in the IG | Not reported | No adverse events | |||
| Second phase | Exercise type: Routine exercise | |||||||
| Mao | China | LVEDVi | LVEDVi, LVESVi, LVEF, BNP peak: No significant differences between two groups | IG: 3.5% | No adverse events | |||
| Nery | Brazil | VO2 peak | VO2 peak: Significant increase in the IG | IG: 0% | No adverse events | |||
| Prabhakaran India | Preinfarct activities score | Preinfarct activities score: Significant improved in the IG | Total 1% | No adverse events | ||||
| Sato | Japan | BRS | BRS: Significant improvement in the IG | Not reported | ||||
| Sharma | India | HDL | HDL, LDL, LVEF: No significant differences were found between the groups | CG: 3% | No adverse events | |||
| Tang | China | 6MWT | 6MWT: Significant increase in the IG | IG: 8% | Not reported | |||
| Yeh | United States | 6MWT | 6MWT, BNP, MLHFQ: Significant improvement in the IG | Not reported | No adverse events | |||
| Yeh | United States | 6MWT | 6MWT, MLHFQ: Significantly improved in the IG | Not reported | No adverse events | |||
| Yeh | United States | n=16, heart failure with preserved ejection fraction (NYHA class I-III), left ventricular ejection fraction ≥50% | 6MWT | BNP, HR, SBP, DBP: No significant differences were found between the groups | Not reported | Not adverse events |
NYHA: New York Heart Association, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, ISWT: Incremental shuttle walk test, MLHFQ: Minnesota living with heart failure questionnaire, SCL-90-R: Symptom checklist-90-revised, AE: Aerobic exercise, VO2: Oxygen consumption, 6MWT: 6 minutes walking test, NT pro-BNP: N-terminal pro-brain natriuretic peptide, MacNewQLMI: MacNew quality of life after myocardial infarction questionnaire, IG: intervention group, CG: control group, HR: Heart rate, PFS: Piper Fatigue Scale, PCI: percutaneous coronary intervention, CAD: Coronary artery disease, CABG: Coronary artery bypass graft, OP: Operation, LVEF: Left ventricular ejection fraction, BMI: Body mass index, SF-36: Self-assessment of health status questionnaire, WHOQOL-BREF: World Health Organization quality of life- brief form questionnaire, QOL: Quality of life, SAQ: Seattle angina questionnaire, , LVEDVi: Left ventricular end-diastolic volume index, LVESVi: Left ventricular end-systolic volume index, LVEF: Left ventricular ejection fraction, BNP: B-type natriuretic peptide, VE peak: Minute ventilation peak, VE/Vco2 slope: Minute ventilation/carbon dioxide production slope, MACE: Major adverse cardiac event, CHD: Coronary heart disease, BRS: Baroreflex sensitivity, HRV: Heart rate variation, LF power: Low-frequency power, HF power: High-frequency power, MI: Myocardial infarction, LDL: Low- density lipoprotein, HDL: High- density lipoprotein, METs: Metabolic equivalents, CDS: Cardiac Depression Scale, HAM-A: Hamilton Anxiety Rating Scale, DASI: Duke activity status, RPE: Rating of Perceived Exertion Scale, HFC: High-frequency coupling, LFC: Low-frequency coupling, POMS: Profile of Mood States
Risk of bias summary: review author’s judgements about each risk of bias item for each included study
| Study, year | Allocation bias | Performance bias | Attrition bias | Detection bias | Reporting bias | Overall bias |
|---|---|---|---|---|---|---|
| Barrow | S | S | H | L | L | H |
| Caminiti | S | S | H | L | L | H |
| Channer | S | S | L | L | L | H |
| Chen | L | S | L | L | L | S |
| Chen | L | S | L | L | L | S |
| Eraballi | L | S | S | S | L | H |
| Lin | S | S | L | S | L | H |
| Mao | S | S | L | L | L | H |
| Nery | L | S | L | L | L | S |
| Prabhakaran | L | S | L | S | L | H |
| Sato | S | S | L | L | L | H |
| Sharma | L | S | L | L | L | S |
| Tang | S | S | L | L | L | H |
| Yeh | S | S | L | L | L | H |
| Yeh | S | S | L | L | L | H |
| Yeh | S | S | L | L | L | H |
L: Low risk of bias, S: Some-concern, H: High risk of bias